← Explorer/Network

Does This Patient Have Erythema Migrans?

Tibbles CD, Edlow JA2007JAMAReview
10.1001/jama.297.23.2617PubMed
DermatologicalImmune/Innate
Lyme & Co-Infections

Abstract

CONTEXT: Erythema migrans, while not pathognomonic, is the most common manifestation of early Lyme disease. Accurate diagnosis of this rash is essential to initiating appropriate antibiotic therapy. OBJECTIVE: To determine the sensitivity of history and physical examination characteristics for the diagnosis of erythema migrans. DATA SOURCES: Structured MEDLINE searches of articles written only in English, 1966 through March 2007. STUDY SELECTION: Studies were included if they enrolled at least 15 consecutive patients with the diagnosis of erythema migrans and reported original data regarding the history and physical examination characteristics of the patients. DATA EXTRACTION: One author abstracted data from the studies. RESULTS: We separately analyzed the studies from Europe and analyzed both Lyme-endemic and nonendemic areas of the United States to search for potential differences in the clinical presentation. Thirty-two studies from Europe, 20 studies from the United States, and 1 from Europe and the United States met inclusion criteria for a total of 8493 patients. Sensitivity was calculated for each of the variables. No studies included patients without erythema migrans, so specificity data and likelihood ratios could not be determined. Many patients do not recall a tick bite. Associated systemic symptoms, such as fever and headache, are frequently reported. Nausea and vomiting are rare. A solitary lesion is the most frequent presentation in both US (81%; 95% confidence interval [CI], 72%-87%) and European patients (88%; 95% CI, 81%-93%). Central clearing is less common in the endemic United States (19%; 95% CI, 11%-32%) vs Europe (79%; 95% CI, 69%-86%) and the nonendemic United States (80%; 95% CI, 63%-90%). CONCLUSIONS: Our analysis of the current available literature suggests that there is no single element in the history or physical examination that is highly sensitive by itself for the diagnosis of erythema migrans. Clinicians should be aware of the wide variability in the clinical presentation of erythema migrans and the need to factor in multiple components of the clinical examination and epidemiological context.

Symptom Clusters

erythema migrans

Cited By (1)

  • Complement split products C3a and C4a are early markers of acute lyme disease in tick bite patients in the United StatesInternational Archives of Allergy and Immunology · 2008

References (5)

  • The early clinical manifestations of Lyme diseaseAnnals of Internal Medicine · 1983
  • Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infectionJAMA · 1992
  • An epidemic of oligoarticular arthritis in children and adults in three connecticut communitiesArthritis & Rheumatism · 1977
  • Treatment of the early manifestations of Lyme diseaseAnnals of Internal Medicine · 1983
  • Isolation of Borrelia burgdorferi from the blood of seven patients with lyme diseaseThe American Journal of Medicine · 1990

Related Papers

  • Human dendritic cells phagocytose and process Borrelia burgdorferiThe Journal of Immunology · 1996 · 3 shared tags
  • Improving the yield of blood cultures for patients with early Lyme diseaseJournal of Clinical Microbiology · 1998 · 3 shared tags
  • Complement split products C3a and C4a are early markers of acute lyme disease in tick bite patients in the United StatesInternational Archives of Allergy and Immunology · 2008 · 3 shared tags
  • CD14 Mediates Cross Talk between Mononuclear Cells and Fibroblasts for Upregulation of Matrix Metalloproteinase 9 byBorrelia burgdorferiInfection and Immunity · 2007 · 3 shared tags
  • Molecular and serological diagnosis of Borrelia burgdorferi infection among patients with diagnosed Erythema migransPubMed · 2007 · 3 shared tags
  • Chemokine Signatures in the Skin Disorders of Lyme Borreliosis in Europe: Predominance of CXCL9 and CXCL10 in Erythema Migrans and Acrodermatitis and CXCL13 in LymphocytomaInfection and Immunity · 2007 ·
3 shared tags